Works matching DE "EMTRICITABINE-tenofovir"

Results: 357

Effects of ursodeoxycholic acid on rilpivirine plasma trough concentrations: a case report.

Published in:

2020

By:

Cattaneo, Dario;
Formenti, Tiziana;
Isabella, Bronzino;
Filice, Carlo;
Fusi, Marta;
Gervasoni, Cristina

Publication type:

Letter

Effect of hepatitis B and C clearance on atazanavir exposure.

Published in:

2015

By:

Gervasoni, Cristina;
Cattaneo, Dario;
Micheli, Valeria;
Cristo, Valentina;
Milazzo, Laura

Publication type:

Letter

The use of oral human immunodeficiency virus pre-exposure prophylaxis in pregnant and lactating women in sub-Saharan Africa: considerations, barriers, and recommendations.

Published in:

Global Health Journal, 2024, v. 8, n. 2, p. 41, doi. 10.1016/j.glohj.2024.04.002

By:

Moyo, Enos;
Murewanhema, Grant;
Moyo, Perseverance;
Dzinamarira, Tafadzwa;
Ross, Andrew

Publication type:

Article

THE EFFECT OF EMTRICITABINE AND TENOFOVIR USE IN THE PRE-EXPOSURE PROFYLAXIS (PrEP) FOR HIV TRANSMISSION.

Published in:

Health & Research Journal, 2020, v. 6, n. 4, p. 101, doi. 10.12681/healthresj.25625

By:

Goula, Maria

Publication type:

Article

Long-Term Stability of the Electronic Sensor Component of a Digital Pill System in Real-World Storage Settings.

Published in:

Journal of Pharmacy Technology, 2021, v. 37, n. 3, p. 135, doi. 10.1177/8755122520985219

By:

Chai, Peter R.;
Goodman, Georgia;
Bustamante, Majo J.;
Mohamed, Yassir;
Castillo-Mancilla, Jose;
Boyer, Edward W.;
Mayer, Kenneth H.;
Rosen, Rochelle K.;
Baumgartner, Susan L.;
Buffkin, Eric;
O'Cleirigh, Conall

Publication type:

Article

Line-field confocal optical coherence tomography for real-time differential diagnosis of toxic epidermal necrolysis versus staphylococcal scalded skin syndrome.

Published in:

Clinical & Experimental Dermatology, 2024, v. 49, n. 12, p. 1704, doi. 10.1093/ced/llae247

By:

Klepfisch, Lucas;
Ben-Said, Benoit;
Ribereau-Gayon, Emmanuel;
Kanitakis, Jean;
Danset, Marie

Publication type:

Article

The Americas.

Published in:: Journal of Global Health, 2012, v. 2, n. 1, p. 4, doi. 10.7189/jogh.02.010201
Publication type:: Article

Drug Resistance During HIV Pre-Exposure Prophylaxis.

Published in:

Drugs, 2019, v. 79, n. 6, p. 609, doi. 10.1007/s40265-019-01108-x

By:

Gibas, Kevin M.;
van den Berg, Polly;
Powell, Victoria E.;
Krakower, Douglas S.

Publication type:

Article

Raltegravir Once-Daily Tablet: A Review in HIV-1 Infection.

Published in:

Drugs, 2017, v. 77, n. 16, p. 1789, doi. 10.1007/s40265-017-0827-9

By:

Deeks, Emma

Publication type:

Article

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection.

Published in:

Drugs, 2016, v. 76, n. 9, p. 957, doi. 10.1007/s40265-016-0586-z

By:

Greig, Sarah;
Deeks, Emma

Publication type:

Article

Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen: A Review of Its Use in HIV Infection.

Published in:

2014

By:

Deeks, Emma

Publication type:

Journal Article

Secrecy, empowerment and protection: positioning PrEP in KwaZulu-Natal, South Africa.

Published in:

2017

By:

Govender, Eliza;
Mansoor, Leila;
MacQueen, Kate;
Abdool Karim, Quarraisha

Publication type:

journal article

When and why women might suspend PrEP use according to perceived seasons of risk: implications for PrEP-specific risk-reduction counselling.

Published in:

2016

By:

Namey, Emily;
Agot, Kawango;
Ahmed, Khatija;
Odhiambo, Jacob;
Skhosana, Joseph;
Guest, Greg;
Corneli, Amy

Publication type:

journal article

Preexposure Prophylaxis--a New Addition to the Armamentarium Against Human Immunodeficiency Virus.

Published in:

Clinical Medicine Insights: Therapeutics, 2017, v. 9, p. 1, doi. 10.1177/1179559X17715241

By:

Kludze, Maabo

Publication type:

Article

Efficacy and Tolerability of Polyphenon E in "Difficult-to-Treat" Multiple Genital Warts in an HIV-Positive Male Subject.

Published in:

Case Reports in Dermatology, 2017, v. 9, n. 2, p. 55, doi. 10.1159/000477839

By:

Grandolfo, Mauro;
Milani, Massimo

Publication type:

Article

Risk of dyslipidaemia in people living with HIV who are taking tenofovir alafenamide: a systematic review and meta‐analysis.

Published in:

Journal of the International AIDS Society, 2024, v. 27, n. 9, p. 1, doi. 10.1002/jia2.26358

By:

Yoo, Jeong‐Ju;
Jung, Eun Ae;
Kim, Sang Gyune;
Kim, Young Seok;
Kim, Min Jae

Publication type:

Article

Using the adherence‐efficacy relationship of emtricitabine and tenofovir disoproxil fumarate to calculate background hiv incidence: a secondary analysis of a randomized, controlled trial.

Published in:

Journal of the International AIDS Society, 2021, v. 24, n. 5, p. 1, doi. 10.1002/jia2.25744

By:

Glidden, David V;
Das, Moupali;
Dunn, David T;
Ebrahimi, Ramin;
Zhao, Yongwu;
Stirrup, Oliver T;
Baeten, Jared M;
Anderson, Peter L

Publication type:

Article

Impact along the HIV pre‐exposure prophylaxis "cascade of prevention" in western Kenya: a mathematical modelling study.

Published in:

Journal of the International AIDS Society, 2020, v. 23, p. 1, doi. 10.1002/jia2.25527

By:

Bershteyn, Anna;
Sharma, Monisha;
Akullian, Adam N;
Peebles, Kathryn;
Sarkar, Supriya;
Braithwaite, R Scott;
Mudimu, Edinah

Publication type:

Article

DIY HIV prevention: Formative qualitative research with men who have sex with men who source PrEP outside of clinical trials.

Published in:

PLoS ONE, 2018, p. 1, doi. 10.1371/journal.pone.0202830

By:

Paparini, Sara;
Nutland, Will;
Rhodes, Tim;
Nguyen, Vinh-Kim;
Anderson, Jane

Publication type:

Article

Prevalence and correlates of persistent intracellular HIV transcription in individuals on efavirenz versus atazanavir-based regimens: A prospective cohort study.

Published in:

PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0194262

By:

Pilalas, Dimitrios;
Skoura, Lemonia;
Margariti, Apostolia;
Chatzopoulou, Fani;
Chatzidimitriou, Dimitrios;
Tsachouridou, Olga;
Zebekakis, Pantelis;
Metallidis, Simeon;
Papaioannou, Maria

Publication type:

Article

Preterm delivery and small-for-gestation outcomes in HIV-infected pregnant women on antiretroviral therapy in rural South Africa: Results from a cohort study, 2010-2015.

Published in:

PLoS ONE, 2018, v. 13, n. 2, p. 1, doi. 10.1371/journal.pone.0192805

By:

Chetty, Terusha;
Thorne, Claire;
Coutsoudis, Anna

Publication type:

Article

Eficacia en vida real del cambio a bictegravir/emtricitabina/tenofovir alafenamida en pacientes previamente tratados con pautas triples que contienen rilpivirina.

Published in:

Revista Española de Quimioterapia, 2022, v. 35, n. 4, p. 378, doi. 10.37201/req/013.2022

By:

de Gea Grela, Alejandro;
Martín Carbonero, Luz;
Micán, Rafael;
Ignacio Bernardino, José;
Ramos, Luis;
Valencia, Maria Eulalia

Publication type:

Article

Hot News.

Published in:

AIDS Reviews, 2022, v. 24, n. 2, p. 97, doi. 10.24875/AIDSRev.M22000048

By:

Treviño, Ana;
Soriano, Vicente

Publication type:

Article

Transmission of Multi-Drug Resistant HIV-1 Despite Antiretroviral Prophylaxis.

Published in:

2017

By:

Soriano, Vicente

Publication type:

Case Study

Current status of the HIV epidemic & challenges in prevention.

Published in:

2017

By:

Karim, Quarraisha

Publication type:

Editorial

Comparison of pharmaceutical characteristics and membrane permeability of truvada combination tablets and its generic drugs.

Published in:

Journal of Generic Medicines, 2023, v. 19, n. 4, p. 186, doi. 10.1177/17411343231191653

By:

Takizawa, Yusuke;
Kunii, Naruya;
Oguri, Junya;
Aizawa, Yuki;
Furuya, Takahito;
Kurita, Takuro;
Masuda, Junichi;
Nakajima, Takanori

Publication type:

Article

Pharmaceutical; Trademark; Patents; News.

Published in:

Journal of Generic Medicines, 2018, v. 14, n. 3, p. 141, doi. 10.1177/1741134318776412

By:

Milchior, Richard;
Charbonnel, Séverine

Publication type:

Article

Review of Real‐World Implementation Data on Emtricitabine‐Tenofovir Disoproxil Fumarate as HIV Pre‐exposure Prophylaxis in the United States.

Published in:

Pharmacotherapy, 2019, v. 39, n. 4, p. 486, doi. 10.1002/phar.2240

By:

Adams, Jessica L.;
Shelley, Karishma;
Nicol, Melanie R.

Publication type:

Article

Plasma and breast milk pharmacokinetics of emtricitabine, tenofovir and lamivudine using dried blood and breast milk spots in nursing African mother--infant pairs.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2018, v. 73, n. 4, p. 1013, doi. 10.1093/jac/dkx507

By:

Waitt, Catriona;
Olagunju, Adeniyi;
Nakalema, Shadia;
Kyohaire, Isabella;
Owen, Andrew;
Lamorde, Mohammed;
Khoo, Saye

Publication type:

Article

High decay of blood HIV reservoir when tenofovir/emtricitabine/elvitegravir/cobicistat is initiated during the acute primary HIV infection.

Published in:

2017

By:

Bell, Elisabeth Carolle Ngo;
Vandenhende, Marie-Anne;
Caldato, Sabrina;
Saunier, Aurélie;
Bellecave, Pantxika;
Tumiotto, Camille;
Avettand-Fenoel, Véronique;
Hessamfar, Mojgan;
Morlat, Philippe;
Bonnet, Fabrice;
Ngo Bell, Elisabeth Carolle

Publication type:

journal article

Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection.

Published in:

2017

By:

Nozza, Silvia;
Poli, Andrea;
Ripa, Marco;
Galli, Laura;
Chiappetta, Stefania;
Spagnuolo, Vincenzo;
Rovelli, Cristina;
Lazzarin, Adriano;
Castagna, Antonella;
Tambussi, Giuseppe

Publication type:

Letter

Different impact of raltegravir versus efavirenz on CD4/CD8 ratio recovery in HIV-infected patients.

Published in:

2017

By:

Serrano-Villar, Sergio;
Yan Zhou;
Rodgers, Anthony J.;
Moreno, Santiago;
Zhou, Yan

Publication type:

journal article

Maraviroc/raltegravir simplification strategy following 6 months of quadruple therapy with tenofovir/emtricitabine/maraviroc/raltegravir in treatment-naive HIV patients.

Published in:

2016

By:

Pradat, Pierre;
Durant, Jacques;
Brochier, Corinne;
Trabaud, Mary-Anne;
Cottalorda-Dufayard, Jacqueline;
Izopet, Jacques;
Raffi, François;
Gatey, Caroline;
Jacomet, Christine;
Vassallo, Matteo;
Dellamonica, Pierre;
Cotte, Laurent;
Lucht, Frédéric;
Gagnieu, Marie-Claude;
No Nuc No Boost Study Group

Publication type:

journal article

A randomized clinical trial comparing ritonavir-boosted lopinavir versus raltegravir each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection.

Published in:

2016

By:

Leal, Lorna;
León, Agathe;
Torres, Berta;
Inciarte, Alexy;
Lucero, Constanza;
Mallolas, Josep;
Laguno, Montserrat;
Martínez-Rebollar, María;
González-Cordón, Ana;
Manzardo, Christian;
Rojas, Jhon;
Pich, Judit;
Arnaiz, Joan A.;
Gatell, Josep M.;
García, Felipe;
RALPEP Study Group

Publication type:

journal article

A randomized clinical trial comparing ritonavir-boosted lopinavir versus maraviroc each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection.

Published in:

2016

By:

Leal, Lorna;
León, Agathe;
Torres, Berta;
Inciarte, Alexy;
Lucero, Constanza;
Mallolas, Josep;
Laguno, Montserrat;
Martínez-Rebollar, María;
González-Cordón, Ana;
Manzardo, Christian;
Rojas, Jhon;
Pich, Judit;
Arnaiz, Joan A.;
Gatell, Josep M.;
García, Felipe;
MARAVIPEP Study Group

Publication type:

journal article

Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART.

Published in:

2016

By:

Lambert-Niclot, S.;
George, E. C.;
Pozniak, A.;
White, E.;
Schwimmer, C.;
Jessen, H.;
Johnson, M.;
Dunn, D.;
Perno, C. F.;
Clotet, B.;
Plettenberg, A.;
Blaxhult, A.;
Palmisano, L.;
Wittkop, L.;
Calvez, V.;
Marcelin, A. G.;
Raffi, F.;
NEAT 001/ANRS 143 Study Group

Publication type:

journal article

Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial.

Published in:

2016

By:

Lortholary, Olivier;
Roussillon, Caroline;
Boucherie, Céline;
Padoin, Christophe;
Chaix, Marie-Laure;
Breton, Guillaume;
Rami, Agathe;
Veziris, Nicolas;
Patey, Olivier;
Caumes, Eric;
May, Thierry;
Molina, Jean-Michel;
Robert, Jérome;
Tod, Michel;
Fagard, Catherine;
Chêne, Geneviève;
ANRS 129 BKVIR Trial Group

Publication type:

journal article

Virological efficacy of abacavir: systematic review and meta-analysis.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 12, p. 3169, doi. 10.1093/jac/dku279

By:

Cruciani, Mario;
Mengoli, Carlo;
Malena, Marina;
Serpelloni, Giovanni;
Parisi, Saverio G.;
Moyle, Graeme;
Bosco, Oliviero

Publication type:

Article

Rapid plasma viral suppression in naive HIV-infected patients with high CD4 cells and low viraemia initiating a dual nucleoside reverse transcriptase inhibitor strategy: a proof-of-concept study.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 12, p. 3356, doi. 10.1093/jac/dku265

By:

Seang, S.;
Fourati, S.;
Keita, Y.;
Blanc, C.;
Tubiana, R.;
Schneider, L.;
Valantin, M. A.;
Caby, F.;
Calin, R.;
Lambert-Niclot, S.;
Marcelin, A.-G.;
Calvez, V.;
Costagliola, D.;
Katlama, C.

Publication type:

Article

Neutrophil gelatinase-associated lipocalin, a marker of tubular dysfunction, is not increased in long-term virologically controlled patients receiving a tenofovir/emtricitabine + nevirapine regimen.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 12, p. 2866, doi. 10.1093/jac/dkt265

By:

Allavena, C.;
Bach-Ngohou, K.;
Billaud, E.;
Sécher, S.;
Dejoie, T.;
Reliquet, V.;
Fakhouri, F.;
Raffi, F.

Publication type:

Article

Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 viruses.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 6, p. 1237, doi. 10.1093/jac/dkt003

By:

Lambert-Niclot, S.;
Charpentier, C.;
Storto, A.;
Fofana, D. B.;
Soulié, C.;
Fourati, S.;
Visseaux, B.;
Wirden, M.;
Morand-Joubert, L.;
Masquelier, B.;
Flandre, P.;
Calvez, V.;
Descamps, D.;
Marcelin, A.-G.

Publication type:

Article

Once daily maraviroc 300 mg or 150 mg in combination with ritonavir-boosted darunavir 800/100 mg.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 3, p. 671, doi. 10.1093/jac/dkr493

By:

Okoli, Chinyere;
Siccardi, Marco;
Thomas-William, Sathish;
Dufty, Ngozi;
Khonyongwa, Kirstin;
Ainsworth, Jonathan;
Watson, John;
Cook, Roseanne;
Gandhi, Kate;
Hickinbottom, Geraldine;
Owen, Andrew;
Taylor, Stephen

Publication type:

Article

Adaptation of a HIV Prevention Mobile App for Transmasculine People: A Pilot Acceptability and Feasibility Study.

Published in:

Transgender Health, 2024, v. 9, n. 6, p. 573, doi. 10.1089/trgh.2023.0041

By:

Jones, Jeb;
Butler, Gareth;
Woody, Meaghan;
Sheets, Martha;
Castel, Amanda D.;
Kulie, Paige;
Scheim, Ayden I.;
Reisner, Sari L.;
Valencia, Rachel;
Wang, Minglun;
Stephenson, Rob;
Stekler, Joanne D.;
Sullivan, Patrick S.

Publication type:

Article

Gender Affirming Hormones Do Not Affect the Exposure and Efficacy of F/TDF or F/TAF for HIV Preexposure Prophylaxis: A Subgroup Analysis from the DISCOVER Trial.

Published in:

Transgender Health, 2024, v. 9, n. 1, p. 46, doi. 10.1089/trgh.2022.0048

By:

Cespedes, Michelle S.;
Das, Moupali;
Yager, Jenna;
Prins, Maria;
Krznaric, Ivanka;
de Jong, Jan;
Xiao, Deqing;
Shao, Yongwu;
Wong, Pamela;
Kintu, Alexander;
Carter, Christoph;
Hoornenborg, Elske;
Ruane, Peter;
Phoenix, John;
Younis, Islam;
Halperin, Jason

Publication type:

Article

Pill related oesophagitis due to tenofovir disproxil fumarate/emtricitabine (Truvada) HIV pre‐exposure prophylaxis.

Published in:

Internal Medicine Journal, 2022, v. 52, n. 6, p. 1099, doi. 10.1111/imj.15807

By:

Bonnichsen, Mark H.;
Tschuchnigg, Mark;
Post, Jeffrey J.;
Bye, William

Publication type:

Article

A multicompartment population PK model to predict tenofovir and emtricitabine mucosal tissue concentrations for HIV prevention.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 12, p. 1922, doi. 10.1002/psp4.13042

By:

Leung, Erick;
Cottrell, Mackenzie L.;
Sykes, Craig;
White, Nicole;
Kashuba, Angela D. M.;
Dumond, Julie B.

Publication type:

Article

Effects of Milk or Apple Juice Ingestion on the Pharmacokinetics of Elvitegravir and Cobicistat in Healthy Japanese Male Volunteers: A Randomized, Single‐Dose, Three‐Way Crossover Study.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 7, p. 737, doi. 10.1002/cpdd.425

By:

Yonemura, Takuma;
Okada, Nozomi;
Sagane, Koichi;
Okamiya, Kazuhiro;
Ozaki, Hideki;
Iida, Toshiaki;
Yamada, Hiroyuki;
Yagura, Hiroki

Publication type:

Article

Intracellular tenofovir‐diphosphate concentrations in HIV pre‐exposure prophylaxis users who underwent bariatric surgery.

Published in:

HIV Medicine, 2025, v. 26, n. 4, p. 643, doi. 10.1111/hiv.13759

By:

McGarrity, Matthew W.;
MacPherson, Paul;
Li, Abby;
Naccarato, Mark;
Anderson, Peter;
Tan, Darrell H. S.

Publication type:

Article

Effectiveness, safety, and patient‐reported outcomes of emtricitabine/tenofovir alafenamide‐based regimens for the treatment of HIV‐1 infection: Final 24‐month results from the prospective German TAFNES cohort study.

Published in:

HIV Medicine, 2025, v. 26, n. 2, p. 239, doi. 10.1111/hiv.13728

By:

Stephan, Christoph;
Spinner, Christoph D.;
Rieke, Ansgar;
Christensen, Stefan;
Mauss, Stefan;
Schreiber, Sandra;
Albuquerque, Boris;
Heinzkill, Marion;
Ramroth, Heribert;
Stellbrink, Hans‐Jürgen

Publication type:

Article

Improvement in insulin sensitivity after switching from an integrase inhibitor‐based regimen to doravirine/tenofovir disoproxil fumarate/lamivudine in people with significant weight gain.

Published in:

HIV Medicine, 2024, v. 25, n. 8, p. 919, doi. 10.1111/hiv.13644

By:

Calza, Leonardo;
Giglia, Maddalena;
Colangeli, Vincenzo;
Bon, Isabella;
Vitale, Salvatore;
Viale, Pierluigi

Publication type:

Article